Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 24;13:286.
doi: 10.1186/1471-2334-13-286.

Cross-sectional Study of Hepatitis B Virus Infection in Rural Communities, Central African Republic

Affiliations
Free PMC article

Cross-sectional Study of Hepatitis B Virus Infection in Rural Communities, Central African Republic

Narcisse P Komas et al. BMC Infect Dis. .
Free PMC article

Abstract

Background: As most data on hepatitis in resource-poor countries relate to urban communities, surveys in the rural environment are necessary to determine the 'true' prevalence of these viral infections. We undertook a survey to determine the prevalence of hepatitis B virus (HBV) infection in an apparently healthy rural population in the Central African Republic (CAR).

Methods: The cross-sectional study was based on dried blood spots (DBS) from 273 people recruited in four prefectures (Lobaye, Nana-Mambéré, Ouham and Ouaka). Eluates from DBS were tested with commercial ELISA kits to detect markers of HBV infection. DBS were directly used for DNA extraction, followed by PCR and genotyping based on preS/S gene sequences.

Results: The overall prevalence of HBc antibodies was 27.1% (Lobaye 29%, Nana-Mambéré 28%, Ouaka 29% and Ouham 23%) and that of HBsAg was 10.6% (Lobaye 9%, Nana-Mambéré 9%, Ouaka 19% and Ouham 8%), with no statistically significant difference among the surveyed communities. Nineteen sequences obtained from 74 anti-HBc-positive patients all belonged to genotype E. Risk factor analysis of HBV infection pointed to sexual transmission of the virus.

Conclusion: The prevalence of HBV is high in rural communities in the CAR and comparable to that observed in urban areas. In addition, genotype E is prevalent in these areas. These findings underline the importance of instituting a programme of active HBV surveillance and vaccination of the population.

Figures

Figure 1
Figure 1
Geographical location of the four surveyed prefectures and their HBsAg and HBc antibody prevalence.
Figure 2
Figure 2
Phylogenetic tree based on 763 nucleotides of the preS (A) (13 strains) and 884 nucleotides of the S (B) (19 strains) gene regions of HBV strains from the Central African Republic (marked with a black dot) and reference strains of recognized and proposed genotypes and closest BLAST fits; GenBank accession numbers are indicated in the tree. Only bootstrap values (n = 1000) ≥ 70 are shown.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles

References

    1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107. doi: 10.1046/j.1365-2893.2003.00487.x. - DOI - PubMed
    1. Garshau W, Mohammed I. Hepatitis B viral markers in Nigerian patients with primary liver carcinoma. Trop Geogr Med. 1991;43:64–67. - PubMed
    1. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37:S9–S19. doi: 10.1111/j.1872-034X.2007.00098.x. - DOI - PubMed
    1. Makuwa M, Souquière S, Telfer P, Apetrei C, Vray M, Bedjabaga I, Mouinga-Ondeme A, Onanga R, Marx PA, Kazanji M, Roques P, Simon F. Identification of hepatitis B virus subgenotype A3 in rural gabon. J Med Virol. 2006;78:1175–1184. doi: 10.1002/jmv.20678. - DOI - PubMed
    1. Nwokediuko SC. Chronic hepatitis B: management challenges in resource-poor countries. Hepat Mon. 2011;11:786–793. - PMC - PubMed

Publication types

Feedback